252 related articles for article (PubMed ID: 36322930)
21. Molecular and clinical features of myeloid neoplasms with somatic DDX41 mutations.
Qu S; Li B; Qin T; Xu Z; Pan L; Hu N; Huang G; Peter Gale R; Xiao Z
Br J Haematol; 2021 Mar; 192(6):1006-1010. PubMed ID: 32307695
[TBL] [Abstract][Full Text] [Related]
22. Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms.
Polprasert C; Schulze I; Sekeres MA; Makishima H; Przychodzen B; Hosono N; Singh J; Padgett RA; Gu X; Phillips JG; Clemente M; Parker Y; Lindner D; Dienes B; Jankowsky E; Saunthararajah Y; Du Y; Oakley K; Nguyen N; Mukherjee S; Pabst C; Godley LA; Churpek JE; Pollyea DA; Krug U; Berdel WE; Klein HU; Dugas M; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Yoshida K; Ogawa S; Müller-Tidow C; Maciejewski JP
Cancer Cell; 2015 May; 27(5):658-70. PubMed ID: 25920683
[TBL] [Abstract][Full Text] [Related]
23. Germline heterozygous DDX41 variants in a subset of familial myelodysplasia and acute myeloid leukemia.
Cardoso SR; Ryan G; Walne AJ; Ellison A; Lowe R; Tummala H; Rio-Machin A; Collopy L; Al Seraihi A; Wallis Y; Page P; Akiki S; Fitzgibbon J; Vulliamy T; Dokal I
Leukemia; 2016 Oct; 30(10):2083-2086. PubMed ID: 27133828
[No Abstract] [Full Text] [Related]
24. Ribosome profiling analysis reveals the roles of DDX41 in translational regulation.
Tungalag S; Shinriki S; Hirayama M; Nagamachi A; Kanai A; Inaba T; Matsui H
Int J Hematol; 2023 Jun; 117(6):876-888. PubMed ID: 36780110
[TBL] [Abstract][Full Text] [Related]
25. DDX41: exploring the roles of a versatile helicase.
Winstone L; Jung Y; Wu Y
Biochem Soc Trans; 2024 Feb; 52(1):395-405. PubMed ID: 38348889
[TBL] [Abstract][Full Text] [Related]
26. Clinical and mechanistic insights into the roles of DDX41 in haematological malignancies.
Weinreb JT; Bowman TV
FEBS Lett; 2022 Nov; 596(21):2736-2745. PubMed ID: 36036093
[TBL] [Abstract][Full Text] [Related]
27. Inherited DDX41 mutations: 11 genes and counting.
Tawana K; Fitzgibbon J
Blood; 2016 Feb; 127(8):960-1. PubMed ID: 26917736
[No Abstract] [Full Text] [Related]
28. Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants.
Bataller A; Loghavi S; Gerstein Y; Bazinet A; Sasaki K; Chien KS; Hammond D; Montalban-Bravo G; Borthakur G; Short N; Issa GC; Kadia TM; Daver N; Tang G; Quesada A; Patel KP; Ravandi F; Fiskus W; Mill CP; Kantarjian HM; Bhalla K; Garcia-Manero G; Oran B; DiNardo CD
Am J Hematol; 2023 Nov; 98(11):1780-1790. PubMed ID: 37665752
[TBL] [Abstract][Full Text] [Related]
29. The emerging roles of the DDX41 protein in immunity and diseases.
Jiang Y; Zhu Y; Liu ZJ; Ouyang S
Protein Cell; 2017 Feb; 8(2):83-89. PubMed ID: 27502187
[TBL] [Abstract][Full Text] [Related]
30. Insights into the Involvement of Spliceosomal Mutations in Myelodysplastic Disorders from Analysis of SACY-1/DDX41 in
Tsukamoto T; Gearhart MD; Kim S; Mekonnen G; Spike CA; Greenstein D
Genetics; 2020 Apr; 214(4):869-893. PubMed ID: 32060018
[TBL] [Abstract][Full Text] [Related]
31. Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia.
Churpek JE; Pyrtel K; Kanchi KL; Shao J; Koboldt D; Miller CA; Shen D; Fulton R; O'Laughlin M; Fronick C; Pusic I; Uy GL; Braunstein EM; Levis M; Ross J; Elliott K; Heath S; Jiang A; Westervelt P; DiPersio JF; Link DC; Walter MJ; Welch J; Wilson R; Ley TJ; Godley LA; Graubert TA
Blood; 2015 Nov; 126(22):2484-90. PubMed ID: 26492932
[TBL] [Abstract][Full Text] [Related]
32. Clinical features of
Wan Z; Han B
Ther Adv Hematol; 2021; 12():20406207211032433. PubMed ID: 34349893
[TBL] [Abstract][Full Text] [Related]
33. Case Report of a Myeloid Neoplasm with Pathogenic Germline Variant in DDX41 and Constitutional inv(7)(q11.2q22) Along With JAK2 Pathogenic Variant in a 9-Year-old Patient Who Presented With Features of Essential Thrombocythemia.
Gray AL; Liu Y; Wappler-Guzzetta EA; Cherukuri D; Wang J; Jain A
J Pediatr Hematol Oncol; 2023 Jul; 45(5):e609-e612. PubMed ID: 37278578
[TBL] [Abstract][Full Text] [Related]
34. DDX41: the poster child for familial AML.
Rio-Machin A; Fitzgibbon J
Blood; 2022 Aug; 140(7):667-669. PubMed ID: 35980681
[No Abstract] [Full Text] [Related]
35. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study.
Duployez N; Largeaud L; Duchmann M; Kim R; Rieunier J; Lambert J; Bidet A; Larcher L; Lemoine J; Delhommeau F; Hirsch P; Fenwarth L; Kosmider O; Decroocq J; Bouvier A; Le Bris Y; Ochmann M; Santagostino A; Adès L; Fenaux P; Thomas X; Micol JB; Gardin C; Itzykson R; Soulier J; Clappier E; Recher C; Preudhomme C; Pigneux A; Dombret H; Delabesse E; Sébert M
Blood; 2022 Aug; 140(7):756-768. PubMed ID: 35443031
[TBL] [Abstract][Full Text] [Related]
36. Comparison between GATA2 and DDX41-mutated myeloid neoplasms.
Nanaa A; He R; Viswanatha D; Nguyen P; Jevremovic D; Foran JM; Yi CA; Greipp PT; Gangat N; Patnaik M; Tefferi A; Litzow MR; Mangaonkar AA; Shah MV; Badar T; Alkhateeb HB; Al-Kali A
Leuk Res; 2022 Oct; 121():106931. PubMed ID: 36037623
[No Abstract] [Full Text] [Related]
37. Unique role of DDX41, a DEAD-box type RNA helicase, in hematopoiesis and leukemogenesis.
Shinriki S; Matsui H
Front Oncol; 2022; 12():992340. PubMed ID: 36119490
[TBL] [Abstract][Full Text] [Related]
38. Biological implications of somatic DDX41 p.R525H mutation in acute myeloid leukemia.
Kadono M; Kanai A; Nagamachi A; Shinriki S; Kawata J; Iwato K; Kyo T; Oshima K; Yokoyama A; Kawamura T; Nagase R; Inoue D; Kitamura T; Inaba T; Ichinohe T; Matsui H
Exp Hematol; 2016 Aug; 44(8):745-754.e4. PubMed ID: 27174803
[TBL] [Abstract][Full Text] [Related]
39. Germline Predisposition to Hematolymphoid Neoplasia.
Weinberg OK; Kuo F; Calvo KR
Am J Clin Pathol; 2019 Aug; 152(3):258-276. PubMed ID: 31309983
[TBL] [Abstract][Full Text] [Related]
40. Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.
Babushok DV; Bessler M; Olson TS
Leuk Lymphoma; 2016; 57(3):520-36. PubMed ID: 26693794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
